Digest Network Come funziona
Network
/
Società
Ju
Non verificato

Juniper Biosciences

Di cosa scriviamo

Annunci EconomiciBiotecnologiaFinanzaMedicina Salute Benessere

5 comunicati stampa

Guarda tutti i comunicati
15/09/2026
Biotecnologia
Annunci Economici
Juniper Biosciences Unveils JBS-002 and JBS-004, Advancing Two Late-Stage Diagnostic Programs to Registration Batch Manufacturing in the Fourth Quarter of 2026
Fonte
Juniper Biosciences
Emittente
GLOBENEWSWIRE
1.00
0
01/09/2026
Biotecnologia
Medicina Salute Benessere
Juniper’s JBS-003 (F-MISO) Program Receives FDA Breakthrough Therapy Designation, Advancing a First-in-Class Hypoxia Tracer Enabling Radiation De-escalation in HPV-Positive Head and Neck Cancer
Fonte
Juniper Biosciences
Emittente
GLOBENEWSWIRE
1.00
0
18/05/2026
Biotecnologia
Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board
Fonte
Juniper Biosciences
Emittente
GLOBENEWSWIRE
1.00
0
28/04/2026
Biotecnologia
Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment
Fonte
Juniper Biosciences
Emittente
GLOBENEWSWIRE
1.00
0
01/12/2025
Biotecnologia
Finanza
Medicina Salute Benessere
Juniper Biosciences Raises Oversubscribed and Upsized $40 Million Seed Financing to Fund Development of Its Innovative Pipeline
Fonte
Juniper Biosciences
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0